<DOC>
	<DOCNO>NCT00599495</DOCNO>
	<brief_summary>The purpose study determine whether reduced intensity condition regimen follow allogeneic stem cell transplantation unrelated donor feasible effective treatment patient multiple myeloma fail previous autologous stem cell transplantation .</brief_summary>
	<brief_title>Matched Unrelated Donor Stem Cell Transplantation ( MUD-SCT ) After Dose-reduced Conditioning Patients With Multiple Myeloma Relapse After Autologous SCT</brief_title>
	<detailed_description>The purpose study determine whether reduced intensity condition regimen follow allogeneic stem cell transplantation unrelated donor feasible effective treatment patient multiple myeloma fail previous autologous stem cell transplantation .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Multiple Myeloma stage II III acc . Salmon Durie ( chemosensitive refractory ) relapse progression high dose chemotherapy autologous stem cell support Age 1860 year ECOGperformance status 01 Availability HLAcompatible unrelated donor ( HLAA , B , DRB1 , DQB1 ) Serious concomitant medical disease would limit life span ability tolerate chemotherapy Severe cardiac failure ( ejection fraction &lt; 40 % ) Severe impairment renal function ( Creatinine clearance &lt; 50ml/min ) Severe impairment liver function ( bilirubine &gt; 2 fold upper limit normal ) Pregnant lactate woman Other major organ system dysfunction ( GI , neurological , psychiatric dysfunction would impair tolerance chemotherapy prolong haematological recovery ) Positivity HIV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Hematopoietic Stem Cell Transplantation</keyword>
	<keyword>Multiple Myeloma</keyword>
</DOC>